alternate names for tirzepatide and ozempic Marketed under like Wegovy, GLP-1 medications have become a popular option weight loss. 📉 However, there are many misconceptions surrounding these medications. Here, we separate fact from fiction Ozempic, Wegovy, And Zepbound (Tirzepatide):

Across all trials, 10,442 participants (44.2%) were female, participants mean HbA 1c at baseline was 66.6 mmol/mol (8.3%), mean body weight was 88.8 kg and mean age was 57.8 years (Table 1)

Ozempic (semaglutide) is a GLP-1 receptor agonist licensed only for type 2 diabetes, not PCOS, in the UK

With upcoming IRA price negotiations, potential PBM rebate structure reforms, and increasing regulatory scrutiny of DTC and compounded GLP-1 providers, employers must stay current with their formulary and coverage decisions

While feeling cold is not one of the most frequently reported side effects, it has been noted by some participants

To be honest, I was not very familiar

Novel therapies in diabetes: a comprehensive narrative review of GLP-1 receptor agonists, SGLT2 inhibitors, and beyond